To achieve the accreditation, Fakeeh University Hospital adopted the internationally recognized “Ten Steps to Successful Breastfeeding” framework developed by WHO and UNICEF.
The acquisition follows Stryker’s earlier move into the vascular intervention market through its approximately US$4.9 billion purchase of Inari Medical in 2025.
Under the partnership, IVI will collaborate closely with institutions such as the Kenya Medical Research Institute, the Kenya BioVax Institute, and the Pharmacy and Poisons Board to support vaccine development, manufacturing, and regulatory strengthening.
Under the partnership, ITWORX Education will implement Avicenna, its advanced Health Information System (HIS) and Enterprise Resource Planning (ERP) platform, across Global Medical City’s hospital ecosystem.
The platform debuted across the UAE, France, Germany, Portugal, and the UK, with additional international rollouts planned in the coming months.
Under the system, 2,100 cases were referred to Egypt’s psychological support hotline 16328, while 1,625 patients were directed to the national electronic mental health and addiction treatment platform.
The next phase will focus on installing and validating fill-and-finish equipment, strengthening quality control systems, building specialized workforce capacity, and preparing for compliant vaccine manufacturing.
Through this collaboration, ZEISS supports the development of innovative imaging applications, provides scientific training opportunities, enables expert demonstrations, and facilitates knowledge exchange among research communities worldwide.
The facility will include inpatient and outpatient psychiatric services, neuro-rehabilitation units, addiction recovery programs, and specialized treatment areas for mood disorders, anxiety disorders, and child and adolescent psychiatry.
The pharmaceutical company submitted bids across several critical childhood immunisation categories, including the Pneumococcal Conjugate Vaccine (PCV10), Rotavirus vaccine, and paediatric Hepatitis B vaccine.